stars 1 stars 2 stars 3

CELLSCRIPT™ provides products and technologies for making and using RNA for translation in cells for clinical research and therapeutics, including RNA comprising pseudouridine (Ψ) and other modified nucleosides covered by patents licensed from the University of Pennsylvania. Products include enzymes and kits for in vitro transcription, co-transcriptional or post-transcriptional 5’ RNA capping, and 3’ RNA polyadenylation.

CELLSCRIPT Questions

The CELLSCRIPT annual revenue was $49.9 million in 2026.

Gary Dahl is the CEO of CELLSCRIPT.

29 people are employed at CELLSCRIPT.

CELLSCRIPT is based in Madison, Wisconsin.

The NAICS codes for CELLSCRIPT are [54, 541, 541714, 5417, 54171].

The SIC codes for CELLSCRIPT are [87, 873].

Top CELLSCRIPT Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users